The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors
Ayad Mohammed Salem,Noor Al Khathlan,Abdulelah Fawzi Alharbi,Turki Alghamdi,Saleh AlDuilej,Mohammed Alghamdi,Majed Alfudhaili,Ahmed Alsunni,Talay Yar,Rabia Latif,Nazish Rafique,Lubna Al Asoom,Hussein Sabit
DOI: https://doi.org/10.2147/IJGM.S319436
IF: 2.145
2021-07-09
International Journal of General Medicine
Abstract:Ayad Mohammed Salem, 1 Noor Al Khathlan, 2 Abdulelah Fawzi Alharbi, 3 Turki Alghamdi, 3 Saleh AlDuilej, 3 Mohammed Alghamdi, 3 Majed Alfudhaili, 3 Ahmed Alsunni, 1 Talay Yar, 1 Rabia Latif, 1 Nazish Rafique, 1 Lubna Al Asoom, 1 Hussein Sabit 4 1 Department of Physiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia; 2 Department of respiratory care, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia; 3 College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia; 4 Department of Genetics, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia Correspondence: Ayad Mohammed Salem Department of Physiology, College of Medicine, Imam Abdulrahman Bin Faisal University, PO Box 2114, Dammam, 31451, Saudi Arabia Email Background: The sequelae of COVID-19 pneumonia on pulmonary function and airways inflammation are still an area of active research. Objective: This research aimed to explore the long-term impact of COVID-19 pneumonia on the lung function after three months from recovery. Methods: Fifty subjects (age 18– 60 years) were recruited and classified into two groups: the control group (30 subjects) and the post-COVID-19 pneumonia group (20 patients). Pulmonary function tests, spirometry, body plethysmography [lung volumes and airway resistance (R aw )], diffusion capacity for carbon monoxide (DL CO ), and fractional exhaled nitric oxide (FeNO), were measured after at least 3 months post-recovery. Results: Significant reduction in total lung capacity (TLC), forced vital capacity (FVC), forced expiratory volume (FEV 1 ), FEV 1 /FEV, and diffusing capacity for carbon monoxide (DL CO ) was observed in post-COVID-19 subjects compared to controls. Restrictive lung impairment was observed in 50% of post-COVID-19 cases (n = 10) compared to 20% in the control group (n = 6, P = 0.026). In addition, mild diffusion defect was detected in 35% (n = 7) of the post-COVID-19 group compared to 23.3% (n = 7) in the controls ( P = 0.012). Conclusion: COVID-19 pneumonia has an impact on the lung functions in terms of restrictive lung impairment and mild diffusion defect after three months from recovery. Therefore, a long-term follow-up of the lung function in post-COVID-19 survivors is recommended. Keywords: COVID-19, pneumonia, PFT, DL CO , FeNO Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the third and largest coronavirus outbreak with more than 152,907,113 million confirmed cases and 3,208,543 deaths as of 2nd of May 2021. 1 COVID-19 originated in China in December 2019 with multiple cases presenting as pneumonia spreading through contact with infected individuals. It spread rapidly across China and quickly spilled over to other countries. The World Health Organization (WHO) declared COVID-19 as a pandemic in March 2020. 2 COVID-19 has an impact on multiple organs such as the heart, 3 kidneys, 4 and liver 5 but the primary system affected has been the respiratory system with most of the clinical manifestations including cough, sputum production, dyspnea, fever, fatigue, and in severe cases acute respiratory distress syndrome (ARDS) and respiratory failure. 6–8 The route of transmission of SARS-CoV-2 is through the respiratory system, the virus invades type 2 alveolar cells in the lung, it attaches to specific angiotensin-converting enzyme 2 (ACE2) receptors, multiplies inside the cells, and elicits inflammatory response with vasodilatation, increased pulmonary capillaries permeability, necrosis of endothelial cells, and in the severe cases this could progress to acute systemic inflammatory responses and cytokine storm. 9 The virus may enter the circulation and cause systemic multiple organ failure especially in tissues having ACE2 receptors such as the heart and kidneys. 10 Autopsy findings of the lung tissue revealed inflammatory cell infiltration and fluid accumulation inside the alveoli, destruction of the alveolar wall, lung fibrosis, and formation of micro-thrombi in the pulmonary capillaries. 11 Long-term follow-up of survivors fro -Abstract Truncated-
medicine, general & internal